What happened
Proteina disclosed an acquisition of ABX Biosciences Co., Ltd., worth US$2.3M.
For context, this deal is worth about 10.8% of the company's own total assets.
| Target | ABX Biosciences Co., Ltd. |
|---|---|
| Deal value | US$2.3M |
| vs. company assets | 10.8% |
| Filed | 2026-07-14, Decision to acquire shares/equity in another company |
| Source | DART rcept 20260714900286 → open original filing |
Source: DART. Information only, not investment advice.